Peter Srajer - ProStar Holdings Chief Scientist
| MAPPF Stock | USD 0.09 0 4.48% |
Insider
Peter Srajer is Chief Scientist of ProStar Holdings
| Phone | 970 242 4024 |
| Web | https://www.prostarcorp.com |
ProStar Holdings Management Efficiency
The company has return on total asset (ROA) of (1.3079) % which means that it has lost $1.3079 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.1961) %, meaning that it generated substantial loss on money invested by shareholders. ProStar Holdings' management efficiency ratios could be used to measure how well ProStar Holdings manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Michael Held | LifeSpeak | N/A | |
| Lilach Kroll | Adcore Inc | N/A | |
| Marie Fryman | RESAAS Services | N/A | |
| Doug Berkowitz | LifeSpeak | N/A | |
| Yossi Elchanan | Adcore Inc | N/A | |
| Lilach Shazar | Adcore Inc | N/A | |
| Yatir CPA | Adcore Inc | N/A | |
| Anna Mittag | LifeSpeak | N/A | |
| Nolan Bederman | LifeSpeak | 51 | |
| Stewart Doma | LifeSpeak | N/A | |
| Stanley Bergman | LifeSpeak | N/A | |
| Jason Bank | LifeSpeak | N/A | |
| Martijn Bemd | Adcore Inc | N/A | |
| Roy Nevo | Adcore Inc | 48 | |
| Raffi Tchakmakjian | LifeSpeak | N/A | |
| Vadim Malkin | Adcore Inc | N/A | |
| Jason Saltzman | Adcore Inc | 52 | |
| Omri Brill | Adcore Inc | 49 | |
| Michael McKenna | LifeSpeak | N/A | |
| Adam MEd | LifeSpeak | N/A | |
| Gal Itkin | Adcore Inc | N/A | |
Management Performance
| Return On Equity | -3.2 | |||
| Return On Asset | -1.31 |
ProStar Holdings Leadership Team
Elected by the shareholders, the ProStar Holdings' board of directors comprises two types of representatives: ProStar Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ProStar. The board's role is to monitor ProStar Holdings' management team and ensure that shareholders' interests are well served. ProStar Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ProStar Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Srajer, Chief Scientist | ||
| Matthew Breman, VP Marketing | ||
| Jess Lyman, VP Sales | ||
| Vasanthan Sivagnanadasan, COO Director | ||
| Jim Anspach, Chair Board | ||
| Page Tucker, CEO Pres |
ProStar Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right otc stock is not an easy task. Is ProStar Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.2 | |||
| Return On Asset | -1.31 | |||
| Operating Margin | (6.18) % | |||
| Current Valuation | 13.89 M | |||
| Shares Outstanding | 116.86 M | |||
| Shares Owned By Insiders | 13.74 % | |||
| Price To Book | 5.59 X | |||
| Price To Sales | 21.19 X | |||
| Revenue | 750.2 K | |||
| Gross Profit | 604.96 K |
Currently Active Assets on Macroaxis
Other Information on Investing in ProStar OTC Stock
ProStar Holdings financial ratios help investors to determine whether ProStar OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ProStar with respect to the benefits of owning ProStar Holdings security.